Ultimovacs Competitors and Similar CompaniesClear all

Ultimovacs's competitors and similar companies include La Jolla Pharmaceutical Company and Pharmacyclics.
Ultimovacs
Ultimovacs
Ultimovacs is a pharmaceutical company developing immunotherapies against cancer.
La Jolla Pharmaceutical Company
La Jolla Pharmaceutical Company
La Jolla Pharmaceutical is a biopharmaceutical company that is focused on innovative therapeutics for chronic organ failure and cancer.
Pharmacyclics
Pharmacyclics
Pharmacyclics Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing innovative small-molecule drugs for the treatment of cancer and immune mediated diseases.
Founding Date
Founding Date
2011
Founding Date
1989
Founding Date
1991
Type
Type
Subsidiary
Type
Public
Type
Subsidiary
Tags
Locations
Locations
Oslo, NO HQ
Uppsala, SE
Locations
San Diego, US HQ
San Diego, US
San Diego, US
Locations
Sunnyvale, US HQ
Employees
Employees
19
Employees
9047% decrease
Employees
6551% decrease

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
$75.7m (FY, 2021)
Revenue (est.)
$729.7m (FY, 2014)
Cost of goods
Cost of goods
N/A
Cost of goods
N/A
Cost of goods
$40.4m (FY, 2014)
Gross profit
Gross profit
N/A
Gross profit
N/A
Gross profit
$689.3m (FY, 2014)
Net income
Net income
(kr140.7m) (FY, 2025)
Net income
$19.7m (FY, 2021)
Net income
$86.1m (FY, 2014)
For sources of this data, please see the company profile

View Company Profiles

La Jolla Pharmaceutical Company
HQ
San Diego, US
Employees
90↓ 47% decrease

La Jolla Pharmaceutical is a biopharmaceutical company that is focused on innovative therapeutics for chronic organ failure and cancer.

View company
Pharmacyclics
HQ
Sunnyvale, US

Pharmacyclics Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing innovative small-molecule drugs for the treatment of cancer and immune mediated diseases.

View company